Carbamazepine
Home / API - Commercial / Carbamazepine
CAS No.
298-46-4
Therapeutic Category
- Anti-convulsant
Innovator Brand
TEGRETOL
GMP
Available
DMF
Not Available
Filed
Under Filing
-
Sample
Available
Indication
Carbamazepine is used to manage and treat epilepsy, trigeminal neuralgia, and acute manic and mixed episodes in bipolar I disorder. Indications for epilepsy are specifically for partial seizures with complex symptomatology (psychomotor, temporal lobe), generalized tonic seizures (grand mal), and mixed seizure patterns.
Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.